+43.1%
GSK vs SUI
-26.4%
+69.5%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SUI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | +0.9% | -1.3% | -0.6% |
| 7D | +0.2% | -1.5% | +1.7% | +0.6% |
| 30D | +5.4% | +3.7% | +1.6% | +4.5% |
| 3M | +0.9% | -0.4% | +1.3% | +0.9% |
| 6M | +0.7% | -2.8% | +3.5% | +1.2% |
| YTD | +5.6% | -1.6% | +7.2% | +5.8% |
| 1Y | +8.5% | -2.1% | +10.6% | +8.8% |
| 3Y | +63.8% | +18.5% | +45.3% | +58.0% |
| All | +43.1% | -26.4% | +69.5% | +48.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SUI.
Daily Out/Under-Performance
Portfolio return minus SUI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SUI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SUI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling